McGill, J. B., Johnson, M., Hurst, S., Cade, W. T., Yarasheski, K. E., Ostlund, R. E., . . . Semenkovich, C. F. (2019, July). Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness. Diabetology & Metabolic Syndrome.
Chicago Style (17th ed.) CitationMcGill, Janet B., et al. "Low Dose Chloroquine Decreases Insulin Resistance in Human Metabolic Syndrome but Does Not Reduce Carotid Intima-media Thickness." Diabetology & Metabolic Syndrome Jul. 2019.
MLA (9th ed.) CitationMcGill, Janet B., et al. "Low Dose Chloroquine Decreases Insulin Resistance in Human Metabolic Syndrome but Does Not Reduce Carotid Intima-media Thickness." Diabetology & Metabolic Syndrome, Jul. 2019.
Warning: These citations may not always be 100% accurate.
